Stockscreener 앱 받기
12.83
7.82%
0.93
시간 외 거래:
12.83
Trevi Therapeutics Inc (TRVI) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Operating Expenses |
37.53%
20.51
|
14.91 | 10.22 | 13.92 | 13.72 |
| Operating Income/Loss |
37.53%
-20.51
|
-14.91 | -10.22 | -13.92 | -13.72 |
| Nonoperating Income/Loss |
58.41%
2.693
|
1.70 | 1.888 | 2.099 | 1.40 |
| Income/Loss From Continuing Operations Before Tax |
34.85%
-17.82
|
-13.21 | -8.332 | -11.82 | -12.32 |
| Income Tax Expense/Benefit |
5.00%
-0.019
|
-0.02 | -0.016 | -0.015 | -0.021 |
| Net Income/Loss |
34.91%
-17.80
|
-13.19 | -8.316 | -11.80 | -12.30 |
| Basic Average Shares |
7.56%
156.60
|
145.59 | - | 145.10 | 130.35 |
| Diluted Average Shares |
7.56%
156.60
|
145.59 | - | 145.10 | 130.35 |
| Basic Earnings Per Share |
22.22%
-0.11
|
-0.09 | - | -0.08 | -0.09 |
| Diluted Earnings Per Share |
22.22%
-0.11
|
-0.09 | - | -0.08 | -0.09 |
5.52%
자본화:
|
볼륨(24시간):